Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 4
2012 2
2013 4
2014 8
2015 4
2016 3
2017 4
2018 4
2019 4
2020 7
Text availability
Article attribute
Article type
Publication date

Search Results

42 results
Results by year
Filters applied: . Clear all
Page 1
Subjective Cognitive Decline Is Associated With Altered Default Mode Network Connectivity in Individuals With a Family History of Alzheimer's Disease.
Verfaillie SCJ, Pichet Binette A, Vachon-Presseau E, Tabrizi S, Savard M, Bellec P, Ossenkoppele R, Scheltens P, van der Flier WM, Breitner JCS, Villeneuve S; PREVENT-AD Research Group. Verfaillie SCJ, et al. Among authors: villeneuve s. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 May;3(5):463-472. doi: 10.1016/j.bpsc.2017.11.012. Epub 2017 Dec 14. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018. PMID: 29735156
Amyloid and Tau Pathology Associations With Personality Traits, Neuropsychiatric Symptoms, and Cognitive Lifestyle in the Preclinical Phases of Sporadic and Autosomal Dominant Alzheimer's Disease.
Pichet Binette A, Vachon-Presseau É, Morris J, Bateman R, Benzinger T, Collins DL, Poirier J, Breitner JCS, Villeneuve S; Dominantly Inherited Alzheimer Network (DIAN); PREVENT-AD Research Group. Pichet Binette A, et al. Among authors: villeneuve s. Biol Psychiatry. 2020 Feb 6:S0006-3223(20)30058-5. doi: 10.1016/j.biopsych.2020.01.023. Online ahead of print. Biol Psychiatry. 2020. PMID: 32228870
Response.
Villeneuve S, Pepin V, Gosselin N, Gagnon K, Gagnon JF. Villeneuve S, et al. Chest. 2013 May;143(5):1512-1513. doi: 10.1378/chest.13-0094. Chest. 2013. PMID: 23648922 No abstract available.
AD molecular: PET amyloid imaging across the Alzheimer's disease spectrum: From disease mechanisms to prevention.
Meyer PF, McSweeney M, Gonneaud J, Villeneuve S. Meyer PF, et al. Among authors: villeneuve s. Prog Mol Biol Transl Sci. 2019;165:63-106. doi: 10.1016/bs.pmbts.2019.05.001. Epub 2019 Jun 8. Prog Mol Biol Transl Sci. 2019. PMID: 31481172 Review.
Data-driven approaches for tau-PET imaging biomarkers in Alzheimer's disease.
Vogel JW, Mattsson N, Iturria-Medina Y, Strandberg OT, Schöll M, Dansereau C, Villeneuve S, van der Flier WM, Scheltens P, Bellec P, Evans AC, Hansson O, Ossenkoppele R; Alzheimer's Disease Neuroimaging Initiative; Swedish BioFINDER Study. Vogel JW, et al. Among authors: villeneuve s. Hum Brain Mapp. 2019 Feb 1;40(2):638-651. doi: 10.1002/hbm.24401. Epub 2018 Oct 19. Hum Brain Mapp. 2019. PMID: 30368979 Free PMC article.
Lifespan Cognitive Reserve-A Secret to Coping With Neurodegenerative Pathology.
Villeneuve S. Villeneuve S. JAMA Neurol. 2019 Oct 1;76(10):1145-1146. doi: 10.1001/jamaneurol.2019.2899. JAMA Neurol. 2019. PMID: 31609408 No abstract available.
Are AD-Typical Regions the Convergence Point of Multiple Pathologies?
Villeneuve S, Wirth M, La Joie R. Villeneuve S, et al. Front Aging Neurosci. 2015 Mar 25;7:42. doi: 10.3389/fnagi.2015.00042. eCollection 2015. Front Aging Neurosci. 2015. PMID: 25859215 Free PMC article. Review. No abstract available.
The potential applications of Apolipoprotein E in personalized medicine.
Villeneuve S, Brisson D, Marchant NL, Gaudet D. Villeneuve S, et al. Front Aging Neurosci. 2014 Jul 8;6:154. doi: 10.3389/fnagi.2014.00154. eCollection 2014. Front Aging Neurosci. 2014. PMID: 25071563 Free PMC article. Review.
Brain properties predict proximity to symptom onset in sporadic Alzheimer's disease.
Vogel JW, Vachon-Presseau E, Pichet Binette A, Tam A, Orban P, La Joie R, Savard M, Picard C, Poirier J, Bellec P, Breitner JCS, Villeneuve S; Alzheimer’s Disease Neuroimaging Initiative* and the PREVENT-AD Research Group. Vogel JW, et al. Among authors: villeneuve s. Brain. 2018 Jun 1;141(6):1871-1883. doi: 10.1093/brain/awy093. Brain. 2018. PMID: 29688388 Free PMC article.
42 results
Jump to page
Feedback